Japanese Insurance Stock News

TSE:9021
TSE:9021Transportation

West Japan Railway (TSE:9021) Valuation Check After Nine Month Results And New 2026 Guidance

West Japan Railway (TSE:9021) has just combined a Q3 2026 earnings call with nine month results to December 31, 2025, along with fresh guidance for the fiscal year ending March 2026. See our latest analysis for West Japan Railway. The earnings release and new guidance appear to have come at a time when momentum in the shares is already building, with a 30 day share price return of 12.73% and a 1 year total shareholder return of 31.45%. If these results have you looking beyond a single railway...
TSE:5802
TSE:5802Auto Components

Sumitomo Electric (TSE:5802) Is Up 12.1% After Upgrading Full-Year Earnings Guidance Has The Bull Case Changed?

In early February 2026, Sumitomo Electric Industries raised its full-year guidance, projecting net sales of ¥4.90 trillion and profit attributable to owners of parent of ¥320.00 billion, after reporting nine-month sales of ¥3.69 trillion and net income of ¥177.21 billion through December 31, 2025. The company’s upgraded outlook, alongside higher basic earnings per share guidance of ¥410.30 versus ¥294.90 previously, highlights a marked improvement in profitability expectations within the...
TSE:7211
TSE:7211Auto

A Look At Mitsubishi Motors (TSE:7211) Valuation After Nine Month Swing To Net Loss

Why Mitsubishi Motors (TSE:7211) is in focus after its latest earnings Mitsubishi Motors (TSE:7211) is back on investors' radar after reporting a net loss of ¥4,489 million for the nine months to December 31, 2025, reversing from net income a year earlier. Sales for the period were ¥1,976,533 million compared with ¥1,989,291 million previously. Basic loss per share from continuing operations reached ¥3.35 versus basic earnings per share of ¥22.8 a year ago. See our latest analysis for...
TSE:4503
TSE:4503Pharmaceuticals

Astellas Pharma (TSE:4503) Is Up 13.9% After Raising FY2026 Guidance On XTANDI Momentum - Has The Bull Case Changed?

In early February 2026, Astellas Pharma Inc. raised its fiscal year ending March 31, 2026 guidance, now projecting revenue of ¥2.10 trillion and higher profits on both core and full-year bases, supported by stronger-than-expected earnings per share. The company attributed these upgraded forecasts to robust global demand for its prostate cancer drug XTANDI and overactive bladder franchise, alongside beneficial foreign exchange effects that lifted expected profitability. Next, we’ll examine...
TSE:7259
TSE:7259Auto Components

Do Stronger Earnings and India Expansion Plans Change The Bull Case For Aisin (TSE:7259)?

Aisin Corporation reported Q3 FY2026 results on February 3, 2026, with nine-month sales of ¥3,769,158 million and net income of ¥107,375 million, alongside higher basic earnings per share from continuing operations year on year. On the same day, Aisin also unveiled plans to invest about ¥32 billion to expand transmission production in India, signalling a long-term commitment to the country’s growing demand for automatic and continuously variable transmissions. We will now examine how these...
TSE:8001
TSE:8001Trade Distributors

Did ITOCHU’s (TSE:8001) New Buyback and Bond Issuance Just Recast Its Capital Efficiency Story?

ITOCHU Corporation recently authorized a share repurchase program of up to 13,000,000 shares for ¥20,000 million and reported nine‑month 2025 revenue of ¥10.99 trillion with net income of ¥705.30 billion, both covering the period ended December 31, 2025. Together with new fixed‑rate unsecured bond issuances, these moves underline how ITOCHU is balancing capital returns with funding flexibility while keeping profitability higher than a year earlier despite slightly lower revenue. Against this...
TSE:4483
TSE:4483Healthcare Services

Asian Value Stocks Trading At A Potential Discount For Savvy Investors

As global markets navigate through volatility marked by concerns over artificial intelligence and geopolitical tensions, value-oriented stocks have begun to capture investor attention, particularly in Asia. Identifying undervalued stocks requires a keen eye for companies with strong fundamentals that may be overlooked due to broader market trends or temporary setbacks.
TSE:8714
TSE:8714Banks

Three Undiscovered Gems In Asia To Enhance Your Investment Portfolio

As global markets experience mixed performances, with small-cap and value-oriented stocks gaining traction amid volatility in large-cap technology sectors, investors are increasingly turning their attention to lesser-known opportunities in Asia. In this dynamic environment, identifying stocks that exhibit strong fundamentals and potential for growth can be key to enhancing an investment portfolio.
TSE:7148
TSE:7148Diversified Financial

Asian Dividend Stocks Featuring Japan Tobacco And Two More Top Picks

As global markets navigate a landscape marked by economic shifts and technological disruptions, Asian equities have shown resilience, with Japan's stock indices rising amid domestic optimism and China's manufacturing sector indicating expansion. In this dynamic environment, dividend stocks can offer a measure of stability through regular income streams, making them attractive to investors seeking reliable returns amidst market volatility.
TSE:6806
TSE:6806Electronic

Hirose Electric (TSE:6806) Valuation Check After Rising Sales But Softer Profits Over Nine Months

What the latest earnings mean for Hirose ElectricLtd (TSE:6806) Hirose ElectricLtd (TSE:6806) has just posted nine month earnings to December 31, 2025, with sales of ¥156,549 million, net income of ¥24,812 million, and lower earnings per share versus a year earlier. See our latest analysis for Hirose ElectricLtd. The latest nine month results, where sales rose year on year but net income and earnings per share softened, have arrived alongside a sharp pickup in momentum. A 7 day share price...